Bayer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bayer and other ETFs, options, and stocks.

About BAYRY

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. 

CEO
William N. Anderson
CEOWilliam N. Anderson
Employees
92,815
Employees92,815
Headquarters
Leverkusen, Nordrhein-Westfalen
HeadquartersLeverkusen, Nordrhein-Westfalen
Founded
1952
Founded1952
Employees
92,815
Employees92,815

BAYRY Key Statistics

Market cap
31.48B
Market cap31.48B
Price-Earnings ratio
-94.35
Price-Earnings ratio-94.35
Dividend yield
0.28%
Dividend yield0.28%
Average volume
474.87K
Average volume474.87K
High today
$8.22
High today$8.22
Low today
$7.52
Low today$7.52
Open price
$8.06
Open price$8.06
Volume
272.42K
Volume272.42K
52 Week high
$8.70
52 Week high$8.70
52 Week low
$4.79
52 Week low$4.79

Stock Snapshot

The current Bayer(BAYRY) stock price is $7.52, with a market capitalization of 31.48B. The stock trades at a price-to-earnings (P/E) ratio of -94.35 and offers a dividend yield of 27.8%.

As of 2025-11-17, Bayer(BAYRY) stock has fluctuated between $7.52 and $8.22. The current price stands at $7.52, placing the stock 0.0% above today's low and -8.5% off the high.

The Bayer(BAYRY)'s current trading volume is 272.42K, compared to an average daily volume of 474.87K.

During the past year, Bayer(BAYRY) stock moved between $4.79 at its lowest and $8.70 at its peak.

During the past year, Bayer(BAYRY) stock moved between $4.79 at its lowest and $8.70 at its peak.

BAYRY News

TipRanks 10h
Galmed’s Aramchol and Bayer’s Stivarga show synergistic effect in GI cancers

Galmed (GLMD) announced results from its joint research with Virginia Commonwealth University, or VCU, evaluating Aramchol’s effect on overcoming drug resistanc...

TipRanks 3d
Bayer price target raised to EUR 30.40 from EUR 26 at Berenberg

Berenberg analyst Sebastian Bray raised the firm’s price target on Bayer (BAYRY) to EUR 30.40 from EUR 26 and keeps a Hold rating on the shares. Meet Your ETF...

TipRanks 4d
Bayer AG Earnings Call: Growth Amid Challenges

Bayer AG ((BAYRY)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst ca...

Analyst ratings

60%

of 20 ratings
Buy
35%
Hold
60%
Sell
5%

More BAYRY News

Benzinga 5d
Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks

On Wednesday, Bayer AG (OTC:BAYRY) reported adjusted earnings of 17 cents per ADS (57 cents in euros), up from 7 cents a year ago (24 cents euros). Sales reach...

Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks
TipRanks 6d
Bayer expects to ‘significantly contain’ litigation risk by end of 2026

CEO Bill Anderson addressed the litigations in the United States. “We’re convinced our multi-pronged strategy is the right one. As we continue to advance it, we...

TipRanks 6d
Bayer confirms group guidance for 2025

Based on the company’s business performance overall in the first nine months of the year, CEO Bill Anderson confirmed the upgraded full-year Group guidance that...

Bloomberg 6d
Bayer Profit Tops Estimates Amid Demand for New Medicines

Industries Bayer Profit Tops Estimates Amid Demand for New Medicines Facebook X LinkedIn Email Link Gift Facebook X LinkedIn Email Link Gift Gift this article C...

Bayer Profit Tops Estimates Amid Demand for New Medicines
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.